Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN111269187A enables phosphorus-free sulfadiazine production. Achieve high purity and reduced waste with our scalable API manufacturing solutions.
Novel patent CN118307620A details a high-yield Dydrogesterone route from 3-bromo-4-methylphenol, offering cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel patent CN105440034B offers high-purity Linagliptin intermediates via selective Mitsunobu reaction ensuring cost reduction and supply reliability for DPP-4 inhibitor manufacturing.
Patent CN102399165B reveals a high-yield Chloramphenicol synthesis using nitromethane, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN105130827A reveals a one-step synthesis for high-purity (R)-phenylglycinol hydrochloride, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN1149192C details a scalable Raney Nickel route for quinolone intermediates, eliminating hazardous reagents and improving purity for reliable API supplier partnerships.
Novel patent CN106966912B enables efficient Dolutegravir intermediate production with high optical purity and scalable manufacturing processes for global supply chains.
Patent CN106188049A reveals a novel route for antitumor intermediates. Discover cost-effective manufacturing and scalable supply chain solutions for high-purity pharmaceutical ingredients.
Discover a transition metal-free synthesis for aza aromatic amines. This patent offers significant cost reduction and high purity for pharmaceutical intermediate manufacturing.
Patent CN114181169A details a green, metal-free route to N-substituted benzothiazin-4-ones, offering cost reduction in fine chemical manufacturing and high purity.
Patent CN121085785A reveals ferrocene-based ligands for asymmetric allylic substitution, offering high enantioselectivity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN104876997A reveals optimized glycyrrhetinic acid modification. Achieve high purity and cost efficiency for pharmaceutical intermediate manufacturing supply chains.
Patent CN116730993A reveals a novel Ir-catalyzed route for Teranavir. Achieve high-purity HIV protease inhibitors with reduced steps and cost reduction in API manufacturing.
Patent CN111620860B reveals a streamlined synthesis for Afuresertib, eliminating complex protection steps for significant cost reduction and supply chain reliability in AKT inhibitor manufacturing.
Patent CN108997332B reveals a safe, high-yield catalytic transfer hydrogenation route for dihydroberberine, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel enzymatic process enhances yield and purity while reducing equipment corrosion for reliable supply chains and cost effective manufacturing solutions in global markets.
Patent CN101875666B details a novel asymmetric synthesis for high-purity 1,3-alkamine compounds, offering significant cost reduction in API manufacturing and reliable supply chain solutions.
Novel Pd-catalyzed method for Z-allyl amino acids via azlactones. High stereoselectivity, mild conditions. Ideal for reliable pharmaceutical intermediate supplier needs.
Patent CN118791500B reveals stable PP5 inhibitors. Enhances supply chain reliability and cost reduction in API manufacturing for oncology.
Patent CN101759759B reveals a high-yield IBX and Bu4NMnO4 route for betulonic acid, offering significant cost reduction and scalability for pharmaceutical intermediates.